Pemphigus vulgaris is a rare autoimmune blistering disorder characterized by the formation of painful blisters on the skin and mucous membranes. In this condition, the immune system mistakenly produces antibodies that attack structural proteins responsible for maintaining adhesion between skin cells. The pemphigus vulgaris disease process leads to the loss of cellular cohesion within the […]
According to global cancer statistics, millions of new cases of prostate cancer are diagnosed each year, making it a major focus area in oncology research. Advancements in molecular biology, biomarker discovery, precision medicine, and immunotherapy have significantly expanded the scope of prostate cancer research, but these breakthroughs depend heavily on access to high-quality biospecimens. At […]
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract. It is characterized by persistent immune activation, mucosal damage, and periods of relapse and remission. Inflammatory bowel disease results from complex interactions between genetic susceptibility, environmental triggers, microbial dysbiosis, and immune dysregulation. This multifactorial process leads to sustained intestinal inflammation and, in […]
Renal cell carcinoma (RCC) is a common form of kidney cancer and accounts for the majority of cancers found in the kidney. Despite major advances in the field of oncology, this disease remains challenging due to its biological heterogeneity, the late-stage diagnosis in many patients, and complex molecular drivers. As a result, renal cell carcinoma […]
Mild Traumatic Brain Injury (TBI), also referred to as “concussion,” is one of the most common neurological injuries worldwide. While traditionally considered transient and self-limiting, research over the past decade has revealed that even mild brain trauma can trigger measurable biochemical, inflammatory, and migraine-related neurobiological changes. For researchers, this shift has transformed how mild TBI […]